Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib

被引：14
|
作者：
Ikezoe, Takayuki [1 ]
Togitani, Kazuto [1 ]
Tasaka, Taizo [2 ]
Nishioka, Chie [1 ]
Yokoyama, Akihito [1 ]
机构：
[1] Kochi Univ, Dept Hematol & Resp Med, Nanko Ku, Kochi 7838505, Japan
[2] Kawasaki Med Sch, Dept Lab Med, Okayama, Japan
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 08期
关键词：
TYROSINE KINASE INHIBITOR; LEUKEMIA;
D O I：
10.1016/j.leukres.2010.02.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E200 / E201
页数：2
相关论文
共 50 条
  • [21] SUCCESSFUL TREATMENT OF HYPEREOSINOPHILIC SYNDROME WITH CYCLOSPORINE
    Donald, C.
    Kahn, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 407 - 407
  • [22] Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation
    Rogers, G.
    Hoyle, M.
    Coon, J. Thompson
    Moxham, T.
    Liu, Z.
    Pitt, M.
    Stein, K.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (22) : 1 - +
  • [23] A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
    Demetri, George D.
    Casali, Paolo G.
    Blay, Jean-Yves
    von Mehren, Margaret
    Morgan, Jeffrey A.
    Bertulli, Rossella
    Ray-Coquard, Isabelle
    Cassier, Philippe
    Davey, Monica
    Borghaei, Hossein
    Pink, Daniel
    Debiec-Rychter, Maria
    Cheung, Wing
    Bailey, Stuart M.
    Veronese, Maria Luisa
    Reichardt, Annette
    Fumagalli, Elena
    Reichardt, Peter
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5910 - 5916
  • [24] Activity in imatinib-resistant leukaemia
    不详
    NATURE REVIEWS CANCER, 2006, 6 (05) : 344 - 344
  • [25] Successful treatment of steroid resistant hypereosinophilic syndrome with low-dose CsA
    Jung, Yun Hwa
    Han, Sang Bong
    Park, Young Jae
    Woo, In Sook
    Cho, Baik Kee
    Han, Chi Wha
    BLOOD RESEARCH, 2013, 48 (04) : 293 - 295
  • [26] Sunitinib for imatinib-resistant GIST
    Joensuu, Heikki
    LANCET, 2006, 368 (9544): : 1303 - 1304
  • [27] Treatment of hypereosinophilic syndrome (HES) with imatinib mesylate.
    Cortes, JE
    Ault, P
    Koller, C
    Thomas, D
    Ferrajoli, A
    Wierda, W
    Rios, MB
    Letvak, L
    Kantarjian, H
    BLOOD, 2002, 100 (11) : 71A - 71A
  • [28] Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome
    Cortes, J
    Ault, P
    Koller, C
    Thomas, D
    Ferrajoli, A
    Wierda, W
    Rios, MB
    Letvak, L
    Kaled, ES
    Kantarjian, H
    BLOOD, 2003, 101 (12) : 4714 - 4716
  • [29] Imatinib treatment-induced cardiomyopathy in hypereosinophilic syndrome
    Tefferi, A
    Pardanani, A
    BLOOD, 2003, 102 (09) : 3457 - 3457
  • [30] Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate
    Ault, P
    Cortes, J
    Koller, C
    Kaled, ES
    Kantarjian, H
    LEUKEMIA RESEARCH, 2002, 26 (09) : 881 - 884
12345